ERO1a promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer. (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.27235

PubMed Identifier: 31666928

Publication URI: http://europepmc.org/abstract/MED/31666928

Type: Journal Article/Review

Volume: 10

Parent Publication: Oncotarget

Issue: 57

ISSN: 1949-2553